In conclusion, the present study demonstrates that overexpression of RASAL2 inhibits PCa cell proliferation, cell migration, and decrease the RAS protooncogene protein, thereby altering RAS pathway, as well as decreasing the TNFα protein proinflammatory master cytokine. The gene discussed is RASAL2; the disease is posterior cortical atrophy.